Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113
- PMID: 33266353
- PMCID: PMC7760216
- DOI: 10.3390/cancers12123587
Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113
Abstract
The authors wish to make the following corrections to this paper [...].
Conflict of interest statement
The authors declare no conflict of interest.
Erratum for
-
Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α.Cancers (Basel). 2020 Jan 1;12(1):113. doi: 10.3390/cancers12010113. Cancers (Basel). 2020. PMID: 31906321 Free PMC article.
References
-
- Aljabali A.A.A., Bakshi H.A., Hakkim F.L., Haggag Y.A., Al-Batanyeh K.M., Al Zoubi M.S., Al-Trad B., Nasef M.M., Satija S., Mehta M., et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α. Cancers. 2020;12:113. doi: 10.3390/cancers12010113. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
